Global Ureteroscopy Market Size By Type (Flexible Ureteroscopes, Semi-Rigid Ureteroscopes), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Ureteroscopy Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. This growth is primarily driven by the rising incidence of urolithiasis and urological disorders, increasing adoption of minimally invasive procedures, and the technological advancements in digital ureteroscopes. Ureteroscopy has become a cornerstone in the diagnosis and treatment of kidney stones and other urinary tract disorders, offering high precision, reduced recovery time, and fewer complications compared to traditional surgical approaches.

Drivers:

1. Rising Prevalence of Urological Disorders:

The increasing global incidence of kidney stones, ureteral tumors, and strictures has propelled the demand for ureteroscopic procedures. The non-invasive nature and effective diagnostic and therapeutic capabilities of ureteroscopy make it a preferred choice among urologists.

2. Advancements in Ureteroscopic Technology:

Significant improvements in digital and fiber-optic ureteroscopes, including better visualization, miniaturization, and durability, are enhancing the efficiency and outcomes of urological procedures. These advancements also support training and procedural standardization.

3. Growing Preference for Minimally Invasive Surgeries:

The healthcare industry’s shift towards minimally invasive techniques is boosting the adoption of ureteroscopy, which offers faster recovery and reduced hospital stays, leading to lower overall healthcare costs.

Restraints:

1. High Cost of Advanced Ureteroscopes:

While technologically advanced ureteroscopes offer improved clinical outcomes, their high acquisition and maintenance costs can hinder adoption, particularly in low- and middle-income countries.

2. Risk of Procedure-Related Complications:

Despite being minimally invasive, ureteroscopy carries risks such as ureteral injury, infection, and the need for retreatment, which can deter patient acceptance and impact procedural efficacy.

Opportunity:

1. Expansion in Emerging Markets:

The increasing healthcare expenditure and improving hospital infrastructure in emerging regions, especially in Asia-Pacific and Latin America, present lucrative growth opportunities for market players offering cost-effective and advanced ureteroscopic solutions.

2. Integration of AI and Imaging Technologies:

The incorporation of artificial intelligence and enhanced imaging in ureteroscopic platforms is expected to revolutionize diagnostic accuracy and therapeutic precision, unlocking new possibilities for personalized treatment.

Market by System Type Insights:

The flexible ureteroscopy segment accounted for the largest market share in 2023, attributed to its superior maneuverability and access to upper urinary tract structures. With continuous advancements in digital visualization and device ergonomics, this segment is expected to maintain its dominance through 2031.

Market by End-use Insights:

Hospitals emerged as the dominant end-use segment in 2023, holding more than 55% of the market share. The availability of skilled professionals, sophisticated equipment, and comprehensive post-operative care drives this preference. Ambulatory Surgical Centers (ASCs) are projected to witness the fastest growth due to increasing demand for same-day procedures and cost-effective healthcare alternatives.

Market by Regional Insights:

North America led the global ureteroscopy market in 2023, driven by high disease prevalence, favorable reimbursement policies, and advanced healthcare infrastructure. Asia-Pacific is expected to register the fastest growth during the forecast period due to rising awareness, expanding medical tourism, and increasing healthcare investment in nations such as India and China.

Competitive Scenario:

Key players in the Global Ureteroscopy Market include Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Richard Wolf GmbH, Stryker Corporation, and PENTAX Medical. These companies are investing in research and development, launching novel products, and entering strategic collaborations to strengthen their global footprint.

Key Market Developments:

In 2023, Olympus launched its next-generation digital flexible ureteroscope with enhanced imaging and durability features.

Boston Scientific expanded its product portfolio in 2024 with the introduction of a reusable semi-rigid ureteroscope designed for smaller healthcare facilities.

In 2025, Karl Storz announced a strategic partnership with AI imaging start-up to develop smart visualization systems for ureteroscopic procedures.

Scope of Work – Global Ureteroscopy Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023–2031) 7.1%

Key Segments by System Type Flexible Ureteroscopes, Semi-rigid Ureteroscopes

Key Segments by End-Use Hospitals, Ambulatory Surgical Centers

Leading Region North America

Key Players Boston Scientific